Men with non-metastatic forms are likely to live 'for many years' after diagnosis when active surveillance and other NCCN ...

Dr. Nicholas James shares why it’s important to identify which patients with high-risk, non-metastatic prostate cancer will ...

Dear W.D.W.: It is completely understandable to be concerned about a PSA level of 18 ng/mL, but you and your urologist have, ...

Prostate cancer is one of the most common cancers in men, but when caught early, it's highly treatable. For Vernon Owens, a ...

Bengaluru: Prostate cancer remains one of the most frequently diagnosed malignancies among men worldwide, including in India.

A breakthrough in prostate cancer treatment is now available in Cincinnati, and it changed one patient's life faster than he ...

To close out Men’s Health Month, the Cancer Connections team sat down with Dr. William Dahut, the American Cancer Society’s ...

More than a decade after beating testicular cancer twice, Colin Egglesfield was diagnosed with prostate cancer. The ...

Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced ...

The TCR report forecasts that by 2032 prostate cancer will increase steadily and remain the number one cancer of concern ...

ArteraAI Prostate analyzes digital pathology images of a prostate cancer biopsy slide to help clinicians predict long-term outcomes.

Prostate cancer focal therapies include cryotherapy, irreversible electroporation ablation (IRE), & high-intensity focused ultrasound (HIFU).